We have not reviewed the charts of United Therapeutics Corporation (UTHR) since Dec. 8, 2017 and then we had a long-term Point and Figure target of $175. Prices finally reached that long-term price target this year.
More from Investing
And here are a few thoughts on how to approach Tesla.
Sellers of the videogame giant's stock have been more aggressive than buyers for several months now -- not a positive sign.
What's going to determine where the market is heading is economic news, the Fed's stance on fighting inflation, and the upcoming earnings season.
Fed behavior has appeared panicked, and rushed if anything, and has appeared in such a way as if it had been conducted by a lumberjack more so than by a surgeon.